MedTrace Logo

Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method

NCT01853397 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2015-04-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety, efficacy, and tolerability of treatment with the Liposonix System (Model 2)using a single pass technique.

Conditions

  • Subcutaneous Adipose Tissue

Interventions

DEVICE

Liposonix System (Model 2)

Sponsors & Collaborators

  • Solta Medical

    lead INDUSTRY

Principal Investigators

  • Mark Jewell, MD · Jewell Plastic Surgery Center

  • Ronald Wheeland, MD · Solta Medical Aesthetic Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01853397 on ClinicalTrials.gov